Velutin Inhibits IL-1β-Induced Nucleus Pulposus Inflammatory and Extracellular Matrix Degradation Attenuating Mouse Intervertebral Disc Degeneration via the NF-κB and MAPK Pathways
- Mediators Inflamm. 2025 Nov 20:2025:9625485. doi: 10.1155/mi/9625485.
- 1. Department of Orthopedics, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing 312000, Zhejiang, China.
- 2. Xianju County Peoples Hospital, Taizhou 318000, Zhejiang, China.
- 3. Center for Rehabilitation Medicine, Department of Orthopedics, Zhejiang Provincial People's Hospital (Affliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
- 4. Department of Orthopedics Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, China.
Intervertebral disk degeneration (IVDD) usually causes lower back pain (LBP). Mechanical stress, trauma, aseptic inflammation, Infection, and genetic susceptibility can accelerate the development of IVDD. Reportedly, proinflammatory cytokines and extracellular matrix (ECM) degradation play significant roles in IVDD progression. Therefore, anti-inflammatory treatments and ECM inhibition can potentially delay the progression of IVDD. Velutin, a natural flavonoid, has the vigorous effects of suppressing inflammation. In this study, we researched the protective effects of velutin and the underlying mechanisms. Additionally, we evaluated its validity in a mouse IVDD model. The results indicated that velutin effectively suppressed interleukin-1β-induced inflammatory mediators. Moreover, our findings revealed the mechanisms of velutin's anti-inflammatory effects. Our results indicate that velutin is a potential therapeutic agent for IVDD.
-
Cat. No.Product NameDescriptionTargetResearch Area
-